HEALTH

Sales down as focus shifts to weight management
It’s been a little more than a year since GlaxoSmithKline Consumer Healthcare announced the return of Alli (orlistat 60 mg capsules) to most stores in the United States and Puerto Rico. Today, the over-the-counter diet aid has reclaimed much of its lost dollar base and its No. 2 spot on the list of best-selling diet aids across total U.S. multi-outlets with $30.8 million in sales for the 52 weeks ended April 17.
FDA approves Jentadueto XR from Boehringer Ingelheim, Lilly
SILVER SPRING, Md. — The Food and Drug Administration has approved Boehringer Ingelheim and Eli Lilly and Co.’s Jentadueto XR (linagliptin and metformin HCl) tablets, the companies announced Tuesday.

The new drug is indicated as a once-daily adjunctive treatment for Type 2 diabetes and works by increasing hormones that stimulate insulin production in the pancreas and that stimulate the liver to produce less glucose.

Perrigo announces FDA approval of store brand equivalent to Flonase

DUBLIN - The national brand equivalent of GlaxoSmithKline's Flonase will soon be shipping to store shelves with the announcement Monday that Perrigo and its partner West-Ward Pharmaceuticals on Tuesday gained approval from the U.S. Food and Drug Administration.

"This product approval and launch demonstrates the power of Perrigo's OTC platform," stated John Hendrickson, Perrigo CEO. "Our team has made significant efforts to bring this important product to our customers and consumers in the U.S."
DSN, Mack Elevation host first-ever Future Leaders Summit

CHICAGO — There are more than 58,000 books dedicated to the subject of leadership for sale on Amazon. Yet, it's still one of the most misunderstood topics in business, Mack Elevation Forum founder and managing director Dan Mack told an audience of almost 150 executives gathered here, Tuesday, at the Chicago Art Institute , setting the stage for the first-ever Future Leaders Summit.
Dr. Reddy’s acquires 6 OTC brands in move into branded consumer care

PRINCETON, N.J. — Dr. Reddy’s is moving beyond prescription drugs and into consumer health care with a new acquisition. The company announced Wednesday that it had purchased six OTC brands from Ducere Pharma, including Doan’s, Bufferin, Nupercainal Ointment, Cruex Nail Gel, Comtrex and Myoflex.
Noxicare refreshes brand in push to educate consumers about NSAID alternatives

CHEVY CHASE, Md. — Natural pain relief brand Noxicare has been in the midst of a rebranding effort aimed at educating consumers about the efficacy of its turmeric-based formulation by refreshing its packaging to include information about Noxicare’s ingredients and introducing a new product.
Janssen’s Invokamet gets expanded indication from FDA

SILVER SPRING, Md. — The Food and Drug Administration on Tuesday approved an expanded indication for Janssen Pharmaceuticals’ diabetes medication Invokamet (canagliflozin and metformin HCl). The drug has been approved as a first-line treatment for adults with type 2 diabetes who aren’t being treated with either canagliflozin or metformin.
Family Flora hits Target stores nationwide

FT. LAUDERDALE, Fla. — America’s Naturals announced Tuesday that its Family Flora supplement is now available nationwide at Target. Prior to this the product — which contains a blend of probiotics and prebiotics — had been available online only.
IM Healthscience’s FDgard hits stores nationwide

SAN DIEGO — IM HealthScience announced Monday that its treatment for functional dyspepsia (FD, characterized by persistent or recurring indigestion), FDGard is now nationally available in the digestive aisle at most Walgreens and CVS Pharmacy stores.

FDGard uses caraway and peppermint oils to manage FD among the one-in-six adults estimated to suffer from the condition.
Bausch + Lomb wins Walmart Supplier of the Year award

LAVAL, Quebec — Valeant Pharmaceuticals announced Monday that its Bausch + Lomb brand has received a Supplier of the Year Award for U.S. manufacturing in the Consumables and Health and Wellness areas.

The award, presented at Walmart’s annual supplier summit, recognized Valeant for its current and long-term investment plans in U.S. manufacturing facilities, in particular, the facilities in Greenville, S.C., and Tampa, Fla., as well as a contact lens manufacturing facility in Rochester, N.Y.